Adtec Europe Limited

P0736 – Efficacy of cold atmospheric plasma versus diclofenac 3% gel in patients with actinic keratoses/field cancerization: preliminary results of a prospective, randomized, rater-blinded study (ACTICAP).

Adtec Healthcare is excited to announce that Leeds Teaching Hospitals NHS Trust will be joining as a trial centre for our randomised controlled trial to evaluate the efficacy of non-thermal gas plasma on sub-clinical wound infection (biofilm) in patients.

Adtec Healthcare congratulates Dr Rotering on his receipt of  the runner up Innovation award at the European Association for Cardio-Thoracic Surgery (EACTS) conference in Vienna on October 7th 2017..

Adtec Healthcare reports the successful wound management of patients with long term chronic ulcers at 2 hospitals in Germany and Switzerland.  Some of these results are included in case studies on the website.

Clinical Trial to investigate the potential benefits of treating Actinic Keratosis with Adtec SteriPlas plasma technology.

Adtec Europe will exhibit at two events in 2017 showcasing our atmospheric pressure gas plasma technology for surface treatment applications in precision engineering.

Plasma processing is a material processing technology that is utilized to modify the chemical and physical properties of a surface.

Adtec Healthcare congratulates the R&D Manager Takuya Urayama on receipt of the second place award for Most Innovative Product at JWC Awards 2017.

Adtec Healthcare is pleased to report on the successful qualification of Adtec SteriPlas gas plasma technology by a hospital in Germany.

We are delighted to be awarded second place in the 'Most Innovative Product:' category at the Journal of Wound Care/ World Union of Wound Healing Societies awards.